Physician profile
Shipra Gupta
NPI 1609168681
$4,905.64
in general payments reported to CMS, 2019-2025
24 companies · $1,212 in 2025
The $1,212 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $244 · 2021: $37.30 · 2022: $821 · 2023: $978 · 2024: $1,508 · 2025: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,698.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,424.88 | 2022-2025 | |
| Alcon Vision LLC | $1,153.66 | 2022-2025 | Clareon, Hydrus Microstent, Rocklatan |
| Sight Sciences, INC. | $488.42 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Mallinckrodt Hospital Products INC. | $344.61 | 2023-2025 | Acthar |
| Allergan, INC. | $280.90 | 2020-2021 | |
| Rxsight INC | $272.23 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Bausch & Lomb Americas INC. | $193.35 | 2022-2025 | Infuse, Vyzulta, Ic-8 Apthera Iol |
| Thea Pharma INC. | $113.12 | 2022-2025 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $100.06 | 2023-2024 | Tecnis Iol, Tecnis Simplicity |
| Aerie Pharmaceuticals, INC. | $68.88 | 2019 | |
| Apellis Pharmaceuticals, INC. | $50.45 | 2024-2025 | Syfovre |
| Astellas Pharma US INC | $49.40 | 2025 | Izervay |
| Novartis Pharmaceuticals Corporation | $47.88 | 2022-2023 | |
| Nova Eye, INC. | $45.48 | 2024 | |
| Sun Pharmaceutical Industries INC. | $38.63 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $36.77 | 2025 | |
| Dompe US, INC. | $36.15 | 2019-2022 | |
| Glaukos Corporation | $29.74 | 2025 | Idosetr |
| Amgen INC. | $29.15 | 2024 | Tepezza |
| Rayner Intraocular Lenses Limited | $26.21 | 2025 | Rayone Spheric, Rayner Cataract Set 1, Rayone Emv |
| Harrow Eye, LLC | $23.87 | 2025 | Iheezo |
| Horizon Therapeutics Plc | $21.30 | 2022 | |
| Shire North American Group INC | $17.84 | 2019 | |
| New World Medical,INC. | $12.66 | 2025 | Via360, Clearpath, Streamline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shipra Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.